As observed in orthotopic CT26-FL3 tumors, both B16F10 and 4T1 tumors were refractory to PD-L1 blockade therapy, while the combination of OxP and PD-L1 trap efficiently reduced the tumor burden (Fig. 6a, b, Supplementary Fig. 13). The gene discussed is CD274; the disease is neoplasm.